Application of Cerebellar tDCS in Aphasia

January 11, 2026 updated by: The University of Hong Kong

Exploring the Effects of a Computerized Naming Intervention Combined With Cerebellar tDCS in Cantonese-Speaking Individuals With Aphasia

The goal of this clinical trial is to learn if adding brain stimulation (cerebellar anodal tDCS) helps a computer-based therapy improve word-finding in Cantonese-speaking adults with aphasia after stroke. It will also check if the stimulation is safe and comfortable.

The main questions it aims to answer are:

Does real brain stimulation during therapy help people name pictures (both objects and actions) better and faster than fake (sham) stimulation?

Are there different effects on naming nouns (objects) versus verbs (actions)? Do any participants feel side effects like tingling or discomfort from the stimulation?

Researchers will compare real brain stimulation to sham (fake) stimulation while everyone gets the same 5-day computer therapy.

Participants will:

Do 60 minutes of computer word-naming practice every day for 5 days, twice (once with real stimulation, once with sham), with at least 2 weeks break in between

Wear a cap with electrodes on the back of the head for the first 20 minutes of each session to receive either real or sham brain stimulation

Name pictures on a computer before and after each 5-day block to measure improvement

Report any feelings or side effects after each session

Study Overview

Detailed Description

Aphasia is a frequent consequence of stroke, affecting about one-third of survivors and leading to significant emotional distress, functional limitations, and reduced social participation, all of which diminish quality of life. Speech-language therapy remains the primary treatment for language impairments, but its effectiveness varies considerably, and recovery is often incomplete. Non-invasive brain stimulation techniques, particularly transcranial direct current stimulation (tDCS), have emerged as promising adjuncts to therapy due to their portability, low cost, ease of use, and ability to enhance neural plasticity and cortical excitability in a polarity-dependent manner (anodal for excitation, cathodal for inhibition).

Traditionally, tDCS has targeted left-hemisphere cortical language areas, but post-stroke brain damage can disrupt current flow due to lesions and fluid accumulation. This has shifted attention to the cerebellum, which is often spared in aphasia, plays roles in linguistic and cognitive processing (especially right posterolateral regions), and connects to language networks. Despite its potential, few studies have examined cerebellar tDCS combined with language therapy for post-stroke aphasia, with existing evidence mostly from small trials in Western languages and limited data on tonal languages like Cantonese.

Additional Technical Information on the Methods

  1. Study design: This study employs a randomized, double-blind, sham-controlled, crossover clinical trial design: participants randomly assigned to either the "tDCS-first" or "sham-first" group; both participants and researchers administering clinical testing and treatment blinded to the type of tDCS delivered until data analysis is concluded and, two independent study coordinators conduct the randomization and facilitate the setup for either active or sham tDCS sessions. Each treatment phase consists of five consecutive daily sessions, in which participants receive 60-minute-computerized naming treatment, with the first 20 minutes involving either active or sham tDCS. A 2-week washout period separates the two phases to minimize carryover effects.
  2. Outcome measures:

    Timed confrontation naming task comprising 120 picture stimuli from the Object and Action Naming Battery (OANB) using the DMDX software for data collection. Each trial starts with a central fixation point displayed for 500 ms, followed immediately by a single picture stimulus presented centrally on the screen. The stimulus remains visible until a response is detected or 5000 ms had elapsed. DMDX records an error if no response is produced within the 2000 ms time limit. The task consisted of 60 trained and 60 untrained words, matched for imageability.

  3. Computerized Naming Treatment - described in "Arms and Interventions" The 60-minute computerized naming treatment was adapted to Cantonese from Fridriksson et al. and delivered using DMDX. The treatment engages all domains of lexical-semantic processing by providing auditory and visual articulatory cues. The program features 100 Cantonese picture stimuli (50 objects and 50 actions) from the OANB, 60 of which included in the outcome naming task (trained items).
  4. Adverse effects questionnaire: Participants were asked about adverse effects such as pain and/or discomfort (e.g., itching, irritation, tingling, or burning) before and after each session. The Wong-Baker FACES Pain Rating Scale was used to assess any tDCS-related discomfort.
  5. tDCS protocol Cerebellar tDCS was delivered using a Soterix Medical MxN High Definition tDCS Stimulator. Intervention described in "Arms and Interventions"

Additional Technical Information on Data Analysis:

R version 4.4.1 used to the statistical analyses on the effects of intervention on naming accuracy and Reaction time (RT). Responses audio-recorded and reviewed for suitability prior to RT analysis; stimuli excluded from the RT analysis if contaminated by extraneous sounds before naming (e.g., coughs, starters, or fillers) or when the response provided is incorrect. RT outliers exceeding 3 standard deviations (SD) from the participants' means removed. Generalized linear mixed-effects models run to assess naming accuracy, while linear mixed-effects (LME) models utilized to evaluate naming RT for correct responses. T-tests employed to compare adverse effects between the sham and active conditions. Individual variability assessed by plotting performance for visual inspection of accuracy and mean RT raw scores and McNemar's test to evaluate changes in naming accuracy for each participant across time (pre- vs. immediate post-treatment), condition (active vs. sham), and grammatical category (nouns vs. verbs).

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • Speech and Neuromodulation Lab
    • Hong Kong SAR
      • Hong Kong, Hong Kong SAR, Hong Kong
        • The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Native Cantonese speakers
  • Age: 40-80 years
  • Diagnosed with aphasia
  • Single left-hemispheric stroke ≥6 months prior
  • Premorbid right-handedness
  • Normal or corrected-to-normal vision
  • Functional hearing (with or without hearing aids)

Exclusion Criteria:

  • History of brain surgery
  • Seizures within past 12 months
  • Conditions contraindicated for tDCS (e.g., metallic implants, pacemakers)
  • Prior neurological treatment (other than stroke-related)
  • Severe cognitive impairment
  • Naming accuracy <10% or >80% on noun/verb naming screening pretestt.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active tDCS
Cerebellar tDCS is delivered using a Soterix Medical MxN High Definition tDCS Stimulator. Real tDCS is applied to the right posterolateral cerebellum, with one anodal electrode (2 mA) placed at PO10 and two return electrodes (-1 mA each) at P10 and O10, using EEG-sized electrodes (external diameter of 1.2 cm) secured in an EEG cap. For real tDCS, participants receive five sessions, each consisting of 20 minutes of 2 mA anodal stimulation with 30-second ramp-up and ramp-down periods, with simultaneous behavioral treatment administered for 60 minutes (additional 40 minutes following active tDCS).

Intervention delivered in two phases (active tDCS or sham tDCS first, order of treatment randomized across participants). Cerebellar tDCS: delivered using a Soterix Medical MxN High Definition tDCS Stimulator.

Real tDCS applied to the right posterolateral cerebellum, with one anodal electrode (2 mA) placed at PO10 and two return electrodes (-1 mA each) at P10 and O10, using EEG-sized electrodes (external diameter of 1.2 cm) secured in an EEG cap. Participants received five sessions of tDCS combined with 60-min behavioral treatment. Real tDCS: delivered in the first 20 minutes of the behavioral intervention, 2 mA anodal stimulation with 30-second ramp-up and ramp-down periods.

Sham tDCS - delivered using a Soterix Medical MxN High Definition tDCS Stimulator with similar montage as the active condition. Electrodes were placed similarly, but the stimulator was turned off after a 30-second ramp-up and ramp-down period.

Computerized Naming Treatment: five consecutive 60-minute sessions. The computerized naming treatment adapted to Cantonese from Fridriksson et al. and delivered using DMDX. Lexical-semantic processing is engaged by providing auditory and visual articulatory cues. DMDX featured 100 Cantonese picture stimuli (50 objects and 50 actions), which have norms for timed-picture- naming in Cantonese. Participants viewed a black-and-white image of an item for 2 seconds, followed by a video showing the lower part of a speaker's face (nose and mouth) articulating the corresponding word. Participants then had up to 7 seconds to judge whether the picture stimulus matched the audio-visual presentation by pressing a "correct" or "incorrect" button.
Sham Comparator: Sham tDCS
For sham tDCS, electrodes were placed similarly, but the stimulator was turned off after a 30-second ramp-up and ramp-down period. Five session, similar procedures for the paired behavioral intervention.

Intervention delivered in two phases (active tDCS or sham tDCS first, order of treatment randomized across participants). Cerebellar tDCS: delivered using a Soterix Medical MxN High Definition tDCS Stimulator.

Real tDCS applied to the right posterolateral cerebellum, with one anodal electrode (2 mA) placed at PO10 and two return electrodes (-1 mA each) at P10 and O10, using EEG-sized electrodes (external diameter of 1.2 cm) secured in an EEG cap. Participants received five sessions of tDCS combined with 60-min behavioral treatment. Real tDCS: delivered in the first 20 minutes of the behavioral intervention, 2 mA anodal stimulation with 30-second ramp-up and ramp-down periods.

Sham tDCS - delivered using a Soterix Medical MxN High Definition tDCS Stimulator with similar montage as the active condition. Electrodes were placed similarly, but the stimulator was turned off after a 30-second ramp-up and ramp-down period.

Computerized Naming Treatment: five consecutive 60-minute sessions. The computerized naming treatment adapted to Cantonese from Fridriksson et al. and delivered using DMDX. Lexical-semantic processing is engaged by providing auditory and visual articulatory cues. DMDX featured 100 Cantonese picture stimuli (50 objects and 50 actions), which have norms for timed-picture- naming in Cantonese. Participants viewed a black-and-white image of an item for 2 seconds, followed by a video showing the lower part of a speaker's face (nose and mouth) articulating the corresponding word. Participants then had up to 7 seconds to judge whether the picture stimulus matched the audio-visual presentation by pressing a "correct" or "incorrect" button.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy on a timed confrontation naming task
Time Frame: - The baseline assessment on 'Day 1' - Outcome measure on 'Day 5'. - Data will be reported "through study completion, an average of 1 year"

The timed confrontation naming task comprises 120 picture stimuli from the Object and Action Naming Battery (OANB) and is set for data collection using DMDX . Participants are instructed to name displayed pictures as quickly and ac-curately as possible using a microphone. Each trial started with a central fixation point displayed for 500 ms, followed immediately by a single picture stimulus presented centrally on the screen. The stimulus remains visible until a response is detected or 5000 ms have elapsed. DMDX records an error if no response was produced within the 2000 ms time limit.

The naming task consists of 60 trained and 60 untrained words, half of them nouns and the other half verbs.

- The baseline assessment on 'Day 1' - Outcome measure on 'Day 5'. - Data will be reported "through study completion, an average of 1 year"
Reaction Time on a timed confrontation naming task
Time Frame: - The baseline assessment on 'Day 1' - Outcome measure on 'Day 5'. - Data will be reported "through study completion, an average of 1 year"

The timed confrontation naming task comprises 120 picture stimuli from the Object and Action Naming Battery (OANB) and is set for data collection using DMDX . Participants are instructed to name displayed pictures as quickly and ac-curately as possible using a microphone. Each trial started with a central fixation point displayed for 500 ms, followed immediately by a single picture stimulus presented centrally on the screen. The stimulus remains visible until a response is detected or 5000 ms have elapsed. DMDX records an error if no response was produced within the 2000 ms time limit.

The naming task consists of 60 trained and 60 untrained words, half of them nouns and the other half verbs.

- The baseline assessment on 'Day 1' - Outcome measure on 'Day 5'. - Data will be reported "through study completion, an average of 1 year"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mehdi Bakhtiar, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2024

Primary Completion (Actual)

April 15, 2024

Study Completion (Actual)

June 1, 2025

Study Registration Dates

First Submitted

December 29, 2025

First Submitted That Met QC Criteria

January 11, 2026

First Posted (Actual)

January 21, 2026

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 11, 2026

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphasia Following Cerebral Infarction

Clinical Trials on anodal right posterolateral cerebellar high-definition tDCS

Subscribe